Baltimore biotechnology firm WindMIL Therapeutics has raised a $32.5 million to support clinical trials and further development for new cancer therapies.
{iframe}https://www.bizjournals.com/baltimore/news/2018/06/18/baltimore-biotech-windmil-therapeutics-raises-32-5.html{/iframe}